JPRN-UMIN000002752尚未招募未知
Renoprotective effect of combination therapy in hypertensive patients with renal diseases. - Renoprotective effect of combination therapy in hypertensive patients with renal diseases.
Division of nephrology, Kanazawa University Hospital0 个研究点目标入组 200 人开始时间: 2009年11月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Uncontrolled hypertension (systolic blood pressure >200 mmHg) No use of carcium channel blocker or diuretics within 1 month Pregnancy or its possibility Hypersensitivity to or contraindication of olmesartan
研究者
相似试验
已完成
3 期
A study to assess the renoprotective effects of the SGLT2 inhibitor Dapagliflozin in non-diabetic patients with proteinuria: a randomized double blind 6-week cross-over trialChronic kidney diseaseNL-OMON47662niversitair Medisch Centrum Groningen20
进行中（未招募）
1 期
This study will assess the effects of dapagliflozin (a drug that is used in patients with Type 2 Diabetes) on lowering the level of urine protein in patients with non-diabetic kidney disease.Chronic kidney diseaseEUCTR2017-001090-16-NLniversity Medical Center Groningen53
已完成
不适用
A comparative study of renoprotective effect of tolvaptan as an alternative treatment for increasing loop diuretics in patients with chronic kidney disease complicated with chronic heart failurechronic heart failure, chronic kidney diseaseJPRN-UMIN000036119Kawashima hospital40
招募中
不适用
Evaluation of the reno-protective effect of multidisciplinary team care in patients with diabetes-induced Chronic kidney diseaseChronic Kidney DiseaseJPRN-UMIN000041796Toda Central General Hospital100
已完成
不适用
Evaluation of renoprotective and hypotensive effects by combined use of irbesartan and amlodipine besilate in elderly patients with hypertension.HypertensionJPRN-UMIN000008841Kanazawa Medical University30